Anew Medical, Inc.

Equities

WENA

US03465T1088

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-06-26 pm EDT			5-day change	1st Jan Change
3 ^USD	-17.13%		+28.21%	-71.96%

Jun. 27	ANEW Medical Partners With Okinawa Research Center to Develop Longevity Drugs	MT
Jun. 27	Anew Medical Forms Strategic Partnership with Japan?s Okinawa Research Center for Longevity Science to Study Klotho Gene	CI

Anew Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

June 20, 2024 at 01:15 pm EDT

Anew Medical, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 0.672044 million compared to USD 0.172483 million a year ago.

Latest news about Anew Medical, Inc.

ANEW Medical Partners With Okinawa Research Center to Develop Longevity Drugs	Jun. 27	MT
Anew Medical Forms Strategic Partnership with Japan?s Okinawa Research Center for Longevity Science to Study Klotho Gene	Jun. 27	CI
Sector Update: Health Care Stocks Softer Late Afternoon	Jun. 26	MT
Top Midday Gainers	Jun. 26	MT
Wall Street Set to Open Marginally Lower Ahead of New Home Sales, GDP Figures	Jun. 26	MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday As Traders Await Fresh Catalysts	Jun. 26	MT
Investors Await New Home Sales, GDP Data as US Futures Mixed in Wednesday's Premarket	Jun. 26	MT
Top Premarket Gainers	Jun. 26	MT
Anew Medical Receives European Patent for Klotho as Treatment for Neurodegenerative Diseases	Jun. 26	MT
Anew Medical, Inc.(NasdaqGM:WENA) added to NASDAQ Composite Index	Jun. 24	CI
Anew Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Jun. 20	CI
Anew Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Jun. 20	CI

Chart Anew Medical, Inc.

Duration

Period

More charts

Company Profile

Anew Medical Inc, located in Omaha, Nebraska, is a provider of biotechnology research and development services. It develops disease modifying therapies to alleviate and reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy. The Company was founded in 1982.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
ANEW MEDICAL, INC.	-71.96%	31.55M
VERTEX PHARMACEUTICALS INCORPORATED	+15.20%	121B
REGENERON PHARMACEUTICALS, INC.	+19.67%	113B
ARGENX SE	+18.95%	26.02B
BIONTECH SE	-23.86%	19.39B
GENMAB A/S	-19.03%	15.91B
BEIGENE, LTD.	-20.90%	15.09B
WUXI APPTEC CO., LTD.	-46.14%	15.06B
SAREPTA THERAPEUTICS, INC.	+63.85%	14.93B
NEUROCRINE BIOSCIENCES, INC.	+4.49%	13.85B

Bio Therapeutic Drugs